Hot Stocks to Watch: Siyata Mobile (SYTA), Protagenic Therapeutics (PTIX), BrainStorm Cell Therapeutics (BCLI), DigiAsia Corp (FAAS), Healthcare Triangle (HCTI), and Novavax (NVAX)

May 19, 2025

DENVER, Colo., May 19, 2025 (247marketnews.com)- The stock market is buzzing with activity as several companies make significant moves that could impact their future trajectories. Here’s a roundup of the latest developments:

📱 Siyata Mobile (NASDAQ:SYTA) – Merging with Core Gaming

Siyata Mobile is set to merge with Core Gaming in a $160 million deal, aiming to tap into the $126 billion global mobile gaming market. Core Gaming boasts 40 million monthly active users and over 600 million downloads across 2,000+ games in 140 countries. The merger is expected to enhance Siyata’s presence in the gaming sector, potentially offering significant returns for shareholders.

🧬 Protagenic Therapeutics (NASDAQ:PTIX) – Merging with Phytanix Bio

Protagenic Therapeutics has announced an all-stock merger with Phytanix Bio, combining their pipelines focused on stress-related and CNS disorders. The merger introduces five preclinical assets and one clinical-stage asset, including treatments for obesity and metabolic disorders. This strategic move aims to diversify and strengthen their portfolio.

🧪 BrainStorm Cell Therapeutics (NASDAQ:BCLI) – FDA Clears Phase 3b Trial for NurOwn®

BrainStorm Cell Therapeutics received FDA clearance to initiate a Phase 3b trial for its NurOwn® therapy targeting amyotrophic lateral sclerosis (ALS). The trial will enroll approximately 200 participants across leading academic medical centers, marking a significant step forward in ALS treatment.

🌐 DigiAsia Corp (NASDAQ:FAAS) – Recent Developments

DigiAsia Corp has been in the news recently, with developments that could influence its market position. Investors are advised to monitor the company’s announcements for potential impacts on its stock performance.

🏥 Healthcare Triangle (NASDAQ:HCTI) – AI and Ransomware Initiatives

Healthcare Triangle is integrating Artificial Intelligence (AI) and Large Language Models (LLMs) into healthcare, positioning itself at the forefront of the AI in healthcare market. Additionally, the company has launched a ransomware prevention initiative aimed at protecting healthcare providers, addressing a growing concern in the sector.

💉 Novavax (NASDAQ:NVAX) – FDA Approval

Novavax’s received an FDA approval that includes a $175 million milestone payment from Sanofi as part of a 2024 licensing agreement.

Stay Tuned: Don’t Miss Out

To ensure you don’t miss future announcements, we encourage you to sign up for additional information

For Investor Relation inquiries or to sign up for updates, please click here.

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

For additional 247marketnews.com Siyata disclosure https://247marketnews.com/syta-siyata/

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (SYTA, NVAX, HCTI, FAAS, BCLI NASDAQ)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.